http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1027037-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e2930d121efc5d86e61f3b89a4f5ea
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1998-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b9dcac19b2b1194a2732c7d1f96658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93c513ec5e34498e2849b27ed0a25cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ce6f3ed89421edab13182bb0d1ca8a
publicationDate 2000-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1027037-A1
titleOfInvention Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
abstract Composition comprising a salt of dichloromethylene bisphosphonic acid (I; clodronate) and silicified microcrystalline cellulose as an oral solid dosage form, is new : Independent claims are also included for the manufacture of the oral dosage forms. ACTIVITY : Hypocalcemic.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7862552-B2
priorityDate 1997-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127447154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586697
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135883348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127864207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819

Total number of triples: 50.